References
- Khantzian EJ, McKenna GJ. Acute toxic and withdrawal reactions associated with drug use and abuse. Ann Intern Med 1979; 90:361–72
- Rainey JM Jr, Crowder MK. Prevalence of phencyclidine in street drug preparations. (Letter) N Engl J Med 1974;290:466–7
- Stillman R, Petersen RC. The paradox of phencyclidine (PCP) abuse. (Editorial) Ann Intern Med 1979;90:428–30
- High on PCP. Emerg Med 1976 Mar;8:264–79
- Luby ED, Cohen BD, Rosenbaum G, et al. Study of a new schizophrenomimetic drug—Sernyl. Arch Neurol Psychiatry 1959;81:363–9
- Rosenbaum G, Cohen BD, Luby ED, et al. Comparison of Sernyl with other drugs: simulation of schizophrenic performance with Sernyl, LSD-25, and amobarbital (Amytal) sodium. Arch Gen Psychiatry 1959;1:651–7
- Luby ED, Gottlieb JS, Cohen BD, et al. Model psychoses and schizophrenia. Am J Psychiatry 1962;119:61–7
- Aronow R, Done AK. Phencyclidine overdose: an emerging concept of management. JACEP 1978;7:56–9
- Yesavage JA, Freman AM. Acute phencyclidine (PCP) intoxication: psychopathology and prognosis. J Clin Psychiatry 1978;39:664–6
- Smith RC, Meltzer HY, Arora RC, et al. Effects of phencyclidine on [3H] catecholamine and [3H]serotonin uptake in synaptosomal preparations from rat brain. Biochem Pharmacol 1977;26:1435–9
- Byck R. Drugs and the treatment of psychiatric disorders. In: Goodman LS, Gilman A, eds. The pharmacological basis of therapeutics. 5th ed. New York: Macmillan 1975:195
- Baldessarini RJ. Schizophrenia. N Engl J Med 1977;297:988–95
- Maayani S, Weinstein H, Ben-Zvi N, et al. Psychotomimetics as anticholinergic agents. I. 1-cyclophenylpiperidine derivatives: anticholinesterase activity and antagonistic activity to acetylcholine. Biochem Pharmacol 1974;23:1263–81
- Albin MS, Orr MD, Bunegin L, et al. Tetrahydroaminoacridine antagonism to narcotic addiction. Exp Neurol 1975;46: 644–8
- Albin MS, Aguirre EM, Albin RL. Tetrahydroaminoacridine (THA). II. Modification of postanesthetic emergence responses and anesthesia sleep-time after ketamine hydrochloride (KH) in the human. In: Arias A, Llaurado R, Nalda MA, et al, eds. Recent progress in anaesthesiology and resuscitation (Proceedings IV European Congress Anesthesiology). New York: Excerpta Medica, 1975:147–50
- Done AK. The toxic emergency: a phencyclidine pin-up. Emerg Med 1978 May; 10:179–82
- Burns RS, Lerner SE, Corrado R. Phencyclidine—states of acute intoxication and fatalities. West J Med 1975;123:345–9
- Burns RS, Lerner SE. Management and treatment of acute phencyclidine intoxications. In Bourne PG, ed. Acute drug abuse emergencies: a treatment manual. New York: Academic Press, 1976:297–305
- Jan KM, Dorsey S, Bornstein A. Hog hog: hyperthermia from phencyclidine. (Letter) N Engl J Med 1978;299:722
- Fauman B, Baker F, Coppleson LW, et al. Psychosis induced by phencyclidine. JACEP 1975;4:223–5
- Slavney PR, Rich GB, Pearlson GD, et al. Phencyclidine abuse and symptomatic mania. Biol Psychiatry 1977;12:697–700
- Rainey JM Jr, Crowder MK. Prolonged psychosis attributed to phencyclidine: report of three cases. Am J Psychiatry 1975;132:1076–8
- Luisada PV. Phencyclidine psychosis: phenomenology and treatment. In Petersen RC, Stillman RC, eds. Phencyclidine: an overview. Washington, DC: National Institute of Drug Abuse, 1978:241–54 (Res Monogr Series No. 21) (GPO No. 017024-00785-4)
- Smith DE, Wesson DR, Buxton ME, et al. The diagnosis and treatment of the PCP abuse syndrome. In: Petersen, Stillman, eds,23 p 236
- Cogen FC, Rigg G, Simmons JL, et al. Phencyclidine-associated acute rhabdomyolysis. Ann Intern Med 1978;88:210–2
- Phencyclidine—a different hallucinogen. Med Lett Drugs Ther 1977;19:70–1